Nukkleus (NUKK) Stock Explodes On Strategic European Aerospace Venture
Nukkleus shares are trading higher on Friday. The stock is gaining following the announcement of a strategic joint venture with Mandragola. read more
Why Medtronic Has Been Stuck for Over 1,100 Days And What Lies Ahead
Medtronic has been stuck in a range for 1,100+ days, with weak triads in its Adhishthana cycle keeping the stock in slump until late 2025. read more
BeOne Medicines Stock Gains Momentum With Early-Stage Trial Success For Pretreated Lymphoma Patients
BeOne Medicines reported positive Phase 1/2 results for sonrotoclax in relapsed or refractory mantle cell lymphoma, with regulatory submissions underway and a Phase 3 trial in progress. read more
Nio Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Latest Ratings for NIO Date Firm Action From To Feb 2022 CLSA Maintains Buy Feb 2022 Barclays Initiates Coverage On Overweight Jan 2022 Macquarie Initiates Coverage On Outperform View More Analyst Ratings for NIO View the Latest Analyst Ratings read more
Ambarella Analysts Increase Their Forecasts After Upbeat Q2 Results
Latest Ratings for AMBA Date Firm Action From To Mar 2022 Stifel Maintains Buy Mar 2022 Morgan Stanley Maintains Overweight Mar 2022 Wells Fargo Maintains Overweight View More Analyst Ratings for AMBA View the Latest Analyst Ratings read more
FDA Tightens Safety Guidelines For Biogen Leqembi Alzheimer’s Therapy
The FDA now requires earlier MRI screening for Alzheimer’s drug Leqembi to detect ARIA-E, a rare but serious side effect, aiming to improve treatment safety for patients. read more
